Literature DB >> 2157859

Identification of C3b-binding regions on herpes simplex virus type 2 glycoprotein C.

C Seidel-Dugan1, M Ponce de Leon, H M Friedman, R J Eisenberg, G H Cohen.   

Abstract

Glycoprotein C from herpes simplex viruses types 1 and 2 (gC-1 and gC-2) acts as a receptor for the C3b fragment of the third component of complement. Our goal is to identify domains on gC involved in C3b receptor activity. Here, we used in-frame linker-insertion mutagenesis of the cloned gene for gC-2 to identify regions of the protein involved in C3b binding. We constructed 41 mutants of gC-2, each having a single, double, or triple insertion of four amino acids at sites spread across the protein. A transient transfection assay was used to characterize the expressed mutant proteins. All of the proteins were expressed on the transfected cell surface, exhibited processing of N-linked oligosaccharides, and bound one or more monoclonal antibodies recognizing distinct antigenic sites on native gC-2. This suggested that each of the mutant proteins was folded into a native structure and that a loss of C3b binding by any of the mutants could be attributed to the disruption of a specific functional domain. When the panel of insertion mutants was assayed for C3b receptor activity, we identified three distinct regions that are important for C3b binding, since an insertion within those regions abolished C3b receptor activity. Region I was located between amino acids 102 and 107, region II was located between residues 222 and 279, and region III was located between residues 307 and 379. In addition, region III has some structural features similar to a conserved motif found in complement receptor 1, the human C3b receptor. Finally, blocking experiments indicated that gC-1 and gC-2 bind to similar locations on the C3b molecule.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2157859      PMCID: PMC249343          DOI: 10.1128/JVI.64.5.1897-1906.1990

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

1.  Immunoglobulin G(Fc)-binding receptors on virions of herpes simplex virus type 1 and transfer of these receptors to the cell surface by infection.

Authors:  M F Para; R B Baucke; P G Spear
Journal:  J Virol       Date:  1980-05       Impact factor: 5.103

2.  Herpes simplex virus type 1 glycoprotein E is not indispensable for viral infectivity.

Authors:  H Neidhardt; C H Schröder; H C Kaerner
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

3.  Serological analysis of herpes simplex virus types 1 and 2 with monoclonal antibodies.

Authors:  L Pereira; D V Dondero; D Gallo; V Devlin; J D Woodie
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

4.  Effect of monoclonal antibodies on limited proteolysis of native glycoprotein gD of herpes simplex virus type 1.

Authors:  R J Eisenberg; D Long; L Pereira; B Hampar; M Zweig; G H Cohen
Journal:  J Virol       Date:  1982-02       Impact factor: 5.103

5.  Purification of glycoprotein gD of herpes simplex virus types 1 and 2 by use of monoclonal antibody.

Authors:  R J Eisenberg; M Ponce de Leon; L Pereira; D Long; G H Cohen
Journal:  J Virol       Date:  1982-03       Impact factor: 5.103

6.  Glycoproteins of herpes simplex virus type 2 as defined by monoclonal antibodies.

Authors:  N Balachandran; D Harnish; W E Rawls; S Bacchetti
Journal:  J Virol       Date:  1982-10       Impact factor: 5.103

7.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

8.  Antigenic variants of herpes simplex virus selected with glycoprotein-specific monoclonal antibodies.

Authors:  T C Holland; S D Marlin; M Levine; J Glorioso
Journal:  J Virol       Date:  1983-02       Impact factor: 5.103

9.  Detection of type-specific antibody to herpes simplex virus type 1 by radioimmunoassay with herpes simplex virus type 1 glycoprotein C purified with monoclonal antibody.

Authors:  A M Arvin; C M Koropchak; A S Yeager; L Pereira
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

10.  Detailed analysis of the portion of the herpes simplex virus type 1 genome encoding glycoprotein C.

Authors:  R J Frink; R Eisenberg; G Cohen; E K Wagner
Journal:  J Virol       Date:  1983-02       Impact factor: 5.103

View more
  16 in total

Review 1.  Complement resistance in microbes.

Authors:  M C Moffitt; M M Frank
Journal:  Springer Semin Immunopathol       Date:  1994

2.  Disulfide bond structure determination and biochemical analysis of glycoprotein C from herpes simplex virus.

Authors:  A H Rux; W T Moore; J D Lambris; W R Abrams; C Peng; H M Friedman; G H Cohen; R J Eisenberg
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

3.  Identification of functional domains in herpes simplex virus 2 glycoprotein B.

Authors:  Wei Li; Tanja J Minova-Foster; Daniel D Norton; Martin I Muggeridge
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

4.  Herpes simplex virus type 1 and 2 glycoprotein C prevents complement-mediated neutralization induced by natural immunoglobulin M antibody.

Authors:  Lauren M Hook; John M Lubinski; Ming Jiang; Michael K Pangburn; Harvey M Friedman
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

5.  A partial cDNA clone of trypomastigote decay-accelerating factor (T-DAF), a developmentally regulated complement inhibitor of Trypanosoma cruzi, has genetic and functional similarities to the human complement inhibitor DAF.

Authors:  D V Tambourgi; T L Kipnis; W D da Silva; K A Joiner; A Sher; S Heath; B F Hall; G B Ogden
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

6.  Factors influencing the interaction of herpes simplex virus glycoprotein C with the third component of complement.

Authors:  H P Huemer; C Larcher; M P Dierich; D Falke
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

7.  Herpes simplex virus type 1 Fc receptor protects infected cells from antibody-dependent cellular cytotoxicity.

Authors:  G Dubin; E Socolof; I Frank; H M Friedman
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

8.  Genetic analysis of type-specific antigenic determinants of herpes simplex virus glycoprotein C.

Authors:  K E Dolter; W F Goins; M Levine; J C Glorioso
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

9.  Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules.

Authors:  R Tal-Singer; C Peng; M Ponce De Leon; W R Abrams; B W Banfield; F Tufaro; G H Cohen; R J Eisenberg
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

10.  Resistance of herpes simplex virus type 2 to neomycin maps to the N-terminal portion of glycoprotein C.

Authors:  A M Oyan; K E Dolter; N Langeland; W F Goins; J C Glorioso; L Haarr; C S Crumpacker
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.